A study to compare the safety and efficacy of BIIB033 to a placebo in patients with first episode of loss of vision due to acute inflammation in the optic nerve

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-006291-39

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the study is to evaluate the efficacy of BIIB033 in subjects with their first episode of unilateral AON.


Critère d'inclusion

  • Acute Optic Neuritis